WADA Status The World Anti-Doping Agency (WADA) added BPC-157 to its Prohibited List under section S0 (Non-Approved Substances)
Signs that warrant medical attention: Erythema spreading beyond 5cm from the injection site, particularly if accompanied by warmth and swelling this pattern is consistent with early cellulitis Purulent discharge from the injection site Fever within 2448 hours of injection A firm, tender nodule that persists beyond 72 hours and is growing rather than resolving If you aspirate blood into the syringe before injection visible blood drawing back into the barrel when you pull the plunger slightly withdraw the needle, discard the syringe, and prepare a new one
A well-formulated 2 % serum with the right pH , vehicle and stability can out-perform a cheap 4 % serum every single time
Given as a series of intramuscular injections, Adequan works throughout the body to support joint health by protecting cartilage and helping restore normal joint function
The GLOW Blend is intended exclusively for in vitro and in vivo (animal) laboratory research and is not intended for human or animal consumption, diagnostic use, or therapeutic use
